Growth Hormone Deficiency ( Ex:2 ) Ex:2 This chapter discusses the regulation of growth hormone (GH) secretion and its decline with aging, nutrition, feedback from insulin-like growth factor-I (IGF-I), and changes in body composition
Furthermore, target individual cytokines (anti-IL-1 glucocorticoids, anti-IL-6 simvastatin/haritaki) and small molecules that modulate upstream regulators such as p53 (nutlin-3a) or inhibit LINE-1-driven inflammatory signaling (nucleoside reverse transcriptase inhibitors like lamivudine) also function as SASP inhibitors
Insulin plays a crucial role in this process by directly impacting theca cells, increasing androgen secretion, stimulating the release of plasminogen activator inhibitor-1, and inhibiting plasmin production
Citation: Stupnisek M, Kokot A, Drmic D, Hrelec Patrlj M, Zenko Sever A, Kolenc D, et al
Individual results may vary, and these peptides may cause side effects or interact with medications